The scanned laser pico-projection (SLPP) method and Stokes-Mueller matrix polarimetry technique are used to distinguish cancer cells with different cytoskeletal organizations and metastatic potencies. The speckle contrast of human bone osteosarcoma cancer cells (U2OS) with different cytoskeletal drug treatments is measured by the SLPP method. The results show that the contrast is directly related to the organization of the microtubules and actin fibers. The Stokes-Mueller matrix polaimetry technique is employed to measure polarization parameters of the same samples. The measurement results are found to be consistent with those obtained using the SLPP method. Finally, the Stokes-Mueller matrix polaimetry technique is used to extract the polarization parameters of cell-pairs with different metastatic potencies. It is shown that the extracted value of the linear phase retardance (β) is particularly sensitive to the organization of the microtubules and actin fibers. Furthermore, the linear phase retardance (β) and depolarization index ( ) are both sensitive to the metastatic potency of the cancer cells. In general, both techniques provide a rapid, noninvasive and label-free approach for distinguishing cancer cells with different cytoskeleton organizations and metastatic potentials, and are thus of significant benefit in evaluating the malignancy of cancer cells.
Scanned Laser Pico Projection and1. Introduction
Cancer is the leading cause of death worldwide, and is responsible for more deaths annually than AIDS, tuberculosis and malaria combined. Moreover, the number of cancer-related deaths is increasing by particularly in poor countries [1] . As a result, many techniques for cancer detection and diagnosis have been proposed. Non-invasive imaging techniques such as radiography, computed tomography (CT), positron emission tomography (PET), ultrasonography (US), magnetic resonance imaging (MRI), and tissue polarimetry provide an effective approach for the clinical diagnosis of many metastatic cancers [2] - [4] . Among the optical non-invasive techniques available for the analysis of biological tissues and cells, optical coherence tomography (OCT), scanned laser picoprojection (SLPP), and Mueller matrix polarimetry are some of the most commonly used [5] - [7] . Savastru et al. [8] proposed a high-resolution OCT technique for the automated detection of cancer positive margins based on an analysis of multiple images acquired from each facet of the tissue specimen. The interpretation results were compared with the histopathology findings. It was shown that the proposed method was capable of detecting cancer positive margins with a sensitivity of 81% and a specificity of 89%. Kut et al. [9] developed a label-free, quantitative OCT system for differentiating cancer regions from non-cancer regions in human brain tissues based on the significantly lower optical attenuation values of the cancer core and infiltrated zones compared to non-cancer white matter. However, the OCT system mentioned in [8] , [9] was complicated and expensive. Huang et al. [10] employed a SLPP technique to characterize the metastatic potency of five pairs of cancerous cell lines and two pairs of non-cancerous cell lines. It was shown that for each cell-pair, the high-metastatic cells had a higher speckle contrast than the low-metastatic cells. He et al. [11] analyzed the multispectral transmitted Mueller matrix transformation (MTT) parameters of unstained thin slices of human cervical and thyroid cancer tissues and showed that for both tissues, the MTT parameters enabled the normal and abnormal areas to be distinguished with a high degree of reliability. The results obtained from [10] , [11] show that the SLPP and Mueller matrix polarimetry are potential tools for cancerous cell detection. Thus, these techniques are also adopted in this study.
The present study uses a SLPP system to analyze the speckle contrast and an optical fullfield Stokes-Mueller polarimetry system to analyze the anisotropic polarization properties of turbid media, respectively. The human bone osteosarcoma cancer cells (U2OS) treated with different cytoskeletal drugs are investigated. In addition, five pairs of low-metastatic and high-metastatic cancer cells from the same origin but with different cytoskeletal organizations are also examined. The absolute values of optical parameters included the linear phase retardance (β) and depolarization index ( ) are then used to distinguish the cancer cells with different drug treatments.
Scanned Laser Pico-Projector (SLPP) Measurement of Speckle Contrast of Single Cancer Cells
SLPP is an emerging solution for projecting large-scale images using compact portable devices such as notebooks or cell phones. SLPPs comprise three laser diodes, namely red, green and blue; with the light emerging from each diode being combined via dichroic elements to form a single white beam. In the present study, a SLPP system is used to project green light onto the surface of the sample (single cancer cells), and the transmitted light is then captured by a digital camera. The speckle contrast at pixel (i, j ) in the captured image is then evaluated as
where P(i, j ) is the gray level of the respective pixel and N is the pixel number of two coordinates. The statistical measure given in Eq. (1) evaluates the difference between the highest and lowest gray values among a contiguous set of pixels [12] . In particular, a high contrast value is obtained when the image has highly constant gray levels, whereas a low contrast value is obtained when the image has highly discontinuous gray levels. In practical terms, a higher contrast implies a lower pixel-pair repetition rate, a more uneven surface, and a higher scattering level. The algorithm of this gray level co-occurrence matrix technique is described in detail in [12] .
Differential Mueller Matrix Formalism for Extracting Optical Properties of Anisotropic Sample
Any optical sample can be modeled as S = M S , where S and S are the input and output Stokes vectors, respectively, and M is the 4 × 4 Mueller matrix of the sample. The general form of this relation is given as ⎡
The use of six input lights with different polarization states (i.e., four linear polarization states (0°, 45°, 90°and 135°) and two circular polarization states (R-and L-)) provides a sufficient number of equations to fully determine the complete Mueller matrix of the sample. The corresponding input Stokes vectors are as follows:
The Mueller matrix of the sample can then be obtained as [13] 
Meanwhile, in calculating the differential matrix, it is assumed that the illuminating beam propagates along the z-axis of a right-handed Cartesian coordinate system. The differential Mueller matrix of the sample can be obtained from an eigenvalue analysis of M as follows [13] , [14] 
where v and λ are the eigenvectors and eigenvalues of matrix M, respectively. The Mueller matrix of a general anisotropic sample can be divided into 16 different elements; with each element describing a different aspect of the optical behavior. Let M LB , M CB , M LD , M CD and M be the macroscopic Mueller matrices describing the linear birefringence (LB), circular birefringence (CB), linear dichroism (LD), circular dichroism (CD) and depolarization (Dep) properties of the sample, respectively. The corresponding differential Mueller matrices, i.e., m CB , m CB , m LD , m CD and m can be found in [13] . The differential Mueller matrix describing the complete LB, CB, LD, CD and Dep properties of the anisotropic optical sample can be obtained by summing m lb , m cb , m ld , m cd and m to give
where α is the retardance axis angle, β is the linear phase retardance, γ is the optical rotation angle, θ d is the linear diattenuation orientation angle, D is the linear diattenuation, and R is the circular diattenuation. In addition, d is the sample thickness and the anomalous dichroism and anomalous Dep are characterized by the differential parameters κ q,u,v and η q,u,v, respectively. (Note that the detailed derivations of α, β, γ, θ d , D and R are presented in [13] .) The differential Mueller matrix describing the depolarization effect can be obtained as [13] 
Performing inverse differentiation on Eq. (6), the depolarization index can be obtained as [14] 
where K 22 and K 33 are the two-dimensional degrees of linear depolarization and K 44 is the degree of circular depolarization.
Experimental Setup and Results

Manipulation of Cytoskeletal Organization
Cytoskeletons consist mainly of microtubules, actin filaments and intermediate fibers.
With their high dynamics, microtubules and actin filaments play a major role in regulation on the morphology, migration and invasion of cancer cells. In the present study, human bone osteosarcoma cancer cells (U2OS) with a density of approximately 5 × 10 3 cells/cm 2 were treated over a period of 2 h with four different cytoskeletal drugs, namely paclitaxel (500 nM) and nocodazole (10 μg/ml) to polymerize and depolymerize the microtubules, respectively as well as jasplakinolide (100 nM) and cytochalasin D (100 nM) to polymerize and depolymerize the actin filaments, respectively. Confocal fluorescence images of the microtubules and actin filaments were obtained over the course of the treatment period, as shown in Fig. 1 . The nocodazole disrupted the microtubule function by binding to various sites on the β-tubulin, thereby suppressing the microtubule polymerization ( Fig. 1(a) ). By contrast, the paclitaxel stabilized the microtubules and reduced their dynamicity, thereby resulting in the massive assembly of free microtubules ( Fig. 1(b) ). The cytochalasin D induced a depolymerization of the actin filaments, as indicated by the dots in Fig. 1(c) . Finally, the jasplakinolide induced actin polymerization and stabilized the actin filaments by inhibiting filament disassembly ( Fig. 1(d) ). In general, the results presented in Fig. 1 confirm that all four drugs produce a discernible change in the microtubule and actin filament organization of the U2OS cells. Notably, the paclitaxel and jasplakinolide induce the aggregation and coherence of thick cytoskeletons, while nocodazole and cytochalasin D induce fragmentation and dispersion of thin cytoskeletons.
Cytoskeletal Organization of Cancer Cells With Different Metastatic Potencies
Alterations of the cytoskeletal structure are demonstrated in transformed cancer cells, including a reduced number of microtubules, a disruption of the stress fibers, and a redistribution of the actin filaments. In other words, the cytoskeletal organization of cancer cells is correlated with their metastatic potency. Thus, in the present study, five pairs of cancer cells with different metastatic potencies were used to confirm the tendencies of the optical parameters obtained by the StokesMueller polarimetry method for the cytoskeletal drug-treated U2OS cells. The selected cell-pairs were as follows: (1) human lung adenocarcinoma cell lines CL1-0 and CL1-5 [15] , (2) mouse breast cell lines 67NR and 4T1 [16] , (3) human cervical adenocarcinoma cell lines HeLa and HeLa-S3 [17] , (4) human ovarian endometrioid carcinoma cell lines OVTW-59-P0 and OVTW-59-P4 [18] , and (5) human esophageal squamous cell lines CE81T-FN low /CE81T-FN high . Note that in each cell-pair, the first cell line has low metastatic potency, while the second cell line has high metastatic potency. As shown in Fig. 2 , the low metastatic CL1-0 and 67NR cells show well-organized microtubules, actin filaments and thick stress fibers. By contrast, the high metastatic CL1-5 and 4T1 cells show disorganized microtubules, fewer stress fibers and disrupted actin filaments. Fig. 3 presents a schematic illustration of the experimental setup used to examine the effect of the cytoskeletal organization on the contrast properties of the light transmitted through the cell under white light and green light illumination. The measurement system comprised a commercial SLPP (model: SHOWWX, MicroVision) with a resolution of WVGA (848 × 480), an aspect ratio of 16:9 Widescreen, a contrast ratio of >5000:1, and an image size capability of 150 to 2500 mm, a halogen light, a microscope objective lens (40×), and a CCD camera. In imaging the sample, the exposure times of the green SLPP laser and white halogen light were set as 17.24 ms and 666.7 ms, respectively. In performing the experiment, the incident angle of SLPP input light was given as 45°. It is noted that the incident angle value of 45°was chosen to achieve the higher scattering coefficient and the better speckle image.
SLPP Measurements of Single Cancer Cells
For each sample, a single projection image with a size of 400 × 255 mm 2 was created using the green laser in the SLPP system. The white light passing through the cell was additionally captured by the digital camera (Olympus IX71) as a microscopic image with a size of 1360 × 1024 pixels. Fig. 4(a) and (b) show the two images obtained of a single cell under green light and white light illumination, respectively. The speckle images were cut into sub-images with a size of 40 × 40 pixels and the contrast information in each image was analyzed using a self-written Matlab program. purposes, the speckle contrast values of non-treated U2OS cells are also shown as a control group. In Fig. 5(a) , the different speckle contrast values of the cells with different drugs are described as (A) -control group and nocodazole treatment, (B) -control group and paclitaxel treatment, and (C) -nocodazole treatment and paclitaxel treatment. In Fig. 5(b) , the different speckle contrast values of the cells with different drugs are described as (A) -control group and cytochalasin D, (B) -control group and jasplakinolide treatment, and (C) -jasplakinolide treatment and cytochalasin D. It is seen that paclitaxel treatment increased the speckle contrast value compared to the control group. By contrast, nocodazole treatment reduced the speckle contrast compared to both the control group and the paclitaxel-treatment group (Fig. 5(a) ). Similarly, jasplakinolide treatment increased the speckle contrast compared to the control group, while cytochalasin D reduced the speckle contrast compared to both the control group and the jasplakinolide-treatment group (Fig. 5(b) ). The results confirm that the polymerization and depolymerization of the microtubules and actin filaments caused by the cytoskeletal drugs have opposite effects on the speckle contrast of the cancer cell images, irrespective of the illumination source used (i.e., white light or green light). It is further seen that green light illumination results in a greater speckle contrast for all four drug treatments due to its greater coherence than white light. Fig. 6 presents a schematic illustration of the Stokes-Mueller matrix polarimetry system used to measure the anisotropic optical properties of cells with and without cytoskeletal drug treatment, respectively. As shown, the system consists mainly of a 15 mW He-Ne laser working at 632.8 nm (JDS Uniphase, 1144P), a fixed horizontal polarizer (SPF-30C-32, Qnset, 400-700 nm), a rotating quarter-waveplate (WPQ10M-633, Thorlabs, λ/8@633 nm), a density filter (NDC-100, Qnset), a CCD camera (1500M-T1-GE, DVC, High QE CCD: > 62% @ 500 nm), and an objective lens (20×).
Stokes-Mueller Matrix Polarimetry Measurements of Groups of Cancer Cells
In performing the experiments, the samples were illuminated by six different polarization lights (namely four linear polarized lights (0°, 45°, 90°and 135°) and two circular polarized lights (R-and L-)). For each input light, the Stokes parameters were measured and used to derive the optical parameters (α, β, γ, θ d , D, R and ) using the method described in Section 3. Note that in setting up the experimental system, the microscope and CCD camera were used to ensure that the sample was placed in the center of the light spot. Both items of equipment were then removed from the system prior to the measurement process. Fig. 7 . Note that for each parameter, results are also presented for a blank group, namely an empty glass-bottom dish. (It is seen that parameter β (i.e., the linear phase retardance) is highly sensitive to the cytoskeletal organization. In Fig. 7(a) , the different speckle contrast values of the cells with different drugs are described as (A) -control group and nocodazole treatment, (B) -control group and paclitaxel treatment, and (C) -nocodazole treatment and paclitaxel treatment. In Fig. 7(b) , the different speckle contrast values of the cells with different drugs are described as (A) -control group and cytochalasin D, (B) -control group and jasplakinolide treatment, and (C) -jasplakinolide treatment and cytochalasin D. In particular, polymerization of the microtubules by paclitaxel treatment increases the β value compared to the non-treatment group, whereas depolymerization of the microtubules by nocodazole treatment reduces the β value compared to both the non-treatment group and the paclitaxel-treatment group (Fig. 7(a) ). Similarly, polymerization of the actin filaments by jasplakinolide treatment increases the β value compared to the non-treatment group, while depolymerization of the actin filaments by cytochalasin D treatment decreases the β value compared to the non-treatment group and the jasplakinolide-treatment group (Fig. 7(b) ). It is noted that the values of α, γ, θ d , D, R and are all relatively insensitive to the cytoskeletal drug treatment. In other words, none of these parameters permit the treated cells to be reliably distinguished from the non-treated cells.
In general, the results presented in Fig. 7 suggest that modification of the cytoskeletal organization by cytoskeletal drugs changes the β values not only of the microtubules, but also of the actin filaments. In other words, the results are consistent with the SLPP findings for single cancer cells, which indicate that skeletal drug treatment leads to an increased speckle contrast as a result of microtubule and actin filament organization change. Cancerous and high-metastatic cells show a highly irregular internal cellular organization compared to normal and non-metastatic cells, such as microtubules and actin filaments. Thus, high β value measurements obtained via Stokes-Mueller polarimetry may indicate a more aggressive cancer with a higher metastatic potency. 
Differentiation of Cancer Cells With Different Metastatic Potencies Using Stokes-Mueller Measurement Technique
The results presented above confirm the feasibility for detecting drug-induced changes of the cytoskeletal organization in U2OS cells via Stokes-Mueller measurement. Accordingly, the StokesMueller polarimetry technique was further used to evaluate the metastatic potencies of five pairs of low-metastatic/high-metastatic cancer cells developed from the same origin but with different cytoskeletal organizations (see Section 4.2). Generally speaking, high-metastatic cells present irregular and dynamic cytoskeletons (e.g., cells treated with depolymerized cytoskeletal drugs such as nocodazole and cytochalasin D for microtubles and actin filaments, respectively). By contrast, low-metastatic cells present regular and stable cytoskeletons (e.g., cells treated with polymerized cytoskeletal drugs such as paclitaxel and jasplakinolide for microtubles and actin filaments, respectively).
Figs. 8 and 9 show the values of α, β, γ, θ d , D, R and obtained for each low-metastatic/highmetastatic cancer cell-pair. Note that the results obtained for a Blank group are also shown for comparison purposes. It is seen that the arrangement and density (β; Fig. 8(a) ) and depolarization ( ; Fig. 8(b) ) of the cytoskeletons exhibit significant differences in all five cell-pairs. In particular, the low-metastatic cells have higher β values than the high-metastatic cells, whereas the high-metastatic cells have higher values than the low-metastatic cells. However, no significant differences are observed between the low-metastatic and high-metastatic cancer cells for the measured values of α, γ, θ d , D and R (Fig. 9) . Low-metastatic cancer cells have a regular arrangement of the inner cytoskeletal structure (i.e., similar to normal differentiated cells) [19] , [20] By contrast, highmetastatic cancer cells have the ability to migrate into other distinct regions, and hence their phenotype develops in such a way as to allow them to move more flexibly and easily [21] , [22] . As a result, high-metastatic cancer cells have a more dynamic and irregular arrangement of the inner cytoskeletal structure. Thus, the value of the phase retardance (β) is reduced compared to that of low-metastatic cells. High-metastatic cells have more stereoscopic outward and an uneven surface [23] , [24] . Consequently, high-metastatic cells have a higher depolarization index than lowmetastatic cells. Huang et al. [10] used a SLPP technique to measure the speckle contrast of the same five low-metastatic/high-metastatic cancer cell-pairs as those considered in the present study. The results showed that the high-metastatic cells had a significantly higher SLPP speckle contrast than the low-metastatic cells. In other words, the tendencies of the SLPP speckle contrast values presented in [10] are consistent with those of the depolarization index ( ) values obtained by Stokes-Mueller polarimetry in the present study.
Conclusion
An SLPP measurement system has been used to evaluate the speckle contrast of single U2OS cancer cells treated with four different skeletal drugs (namely paclitaxel, nocodazole, jasplakinolide and cytochalasin D). The LB, CB, LD, CD and Dep properties of the drug-treated cells have additionally been extracted using a Stokes-Mueller matrix polarimetry technique. Finally, the StokesMueller matrix polarimetry method has been used to measure the anisotropic polarization properties of five low-metastatic / high-metastatic potency cancer cell-pairs. The results have shown that polymerization of the cytoskeleton of the U2OS cells increases the speckle contrast, whereas depolymerization decreases the speckle contrast. Of the seven optical parameters extracted by the Stokes-Mueller polarimetry technique for the drug-treated U2OS cells, only the phase retardance (β) is sensitive to the change in arrangement and density of the cytoskeletons (microtubules and actin filaments) under the effects of the skeletal drugs. Moreover, only the phase retardance (β) and depolarization ( ) values exhibit an obvious difference between the low-metastatic and highmetastatic cells in each cell-pair. Notably, the Stokes-Mueller polarimetry results obtained in this study are consistent with both the present SLPP results for the drug-treated U2OS cells and the SLPP results for the same low-metastatic / high-metastatic cell lines presented in [10] . Overall, the results indicate that both methods (SLPP and Stokes-Mueller matrix polarimetry) provide a feasible means of distinguishing the cytoskeleton organization and metastatic potency of cancer cells.
